検索結果 - Jaume Capdevila

結果の絞り込み
  1. 1
    Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib

    Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib 著者: Jaume Capdevila, Neda Stjepanovic

    出版事項 2014
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    GEP–NETs UPDATE: Biotherapy for neuroendocrine tumours

    GEP–NETs UPDATE: Biotherapy for neuroendocrine tumours 著者: Teresa Alonso‐Gordoa, Jaume Capdevila, Enrique Grande

    出版事項 2014
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies

    Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies 著者: Enrique Grande, Juan J. Díez, Carles Zafón, Jaume Capdevila

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer

    Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer 著者: Anubha Gupta, Barbara Jarząb, Jaume Capdevila, Robert Shumaker, Ziad Hussein

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    What is the status of immunotherapy in thyroid neoplasms?

    What is the status of immunotherapy in thyroid neoplasms? 著者: Alejandro García‐Álvarez, Jorge Hernando, Ana Carmona-Alonso, Jaume Capdevila

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  6. 6
    Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era

    Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era 著者: Jaume Capdevila, Ahmad Awada, Dagmar Führer‐Sakel, Sophie Leboulleux, Patrick Pauwels

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  7. 7
    Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia

    Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia 著者: Rodrigo A. Toledo, Camilo Jiménez, Gustavo Armaiz-Peña, Carlota Arenillas, Jaume Capdevila, Patricia L. M. Dahia

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Cabozantinib for the treatment of solid tumors: a systematic review

    Cabozantinib for the treatment of solid tumors: a systematic review 著者: Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  9. 9
    Genomics Review of Selective <scp>RET</scp> Inhibitors Sensitivity in Thyroid Cancer Clinical Trials

    Genomics Review of Selective <scp>RET</scp> Inhibitors Sensitivity in Thyroid Cancer Clinical Trials 著者: Sara Gil‐Bernabé, Lucía García‐DeLaFuente, Alejandro García‐Álvarez, Ginesa García‐Rostán, Jaume Capdevila, Jorge Hernando

    出版事項 2025
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  10. 10
    Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors

    Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors 著者: Jaume Capdevila, Michel Ducreux, Rocio García‐Carbonero, Enrique Grande, Þorvarður R. Hálfdánarson, Anne Couvelard, Salvatore Tafuto, Staffan Welin, Vicente Valentí, Ramón Salazar

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  11. 11
    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies 著者: Enrique Grande, Michael C. Kreißl, Sébastiano Filetti, Kate Newbold, Walter Reinisch, Caroline Robert, Martin Schlumberger, Lærke Kjær Tolstrup, José Luís Zamorano, Jaume Capdevila

    出版事項 2013
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  12. 12
    Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development

    Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in dev... 著者: Rocio García‐Carbonero, Roberto García‐Figueiras, Alberto Carmona‐Bayonas, Isabel Sevilla, Àlex Teulé, María Quindós, Enrique Grande, Jaume Capdevila, Javier Aller, Javier Arbizu, Paula Jiménez‐Fonseca

    出版事項 2015
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  13. 13
    Sorafenib in metastatic thyroid cancer

    Sorafenib in metastatic thyroid cancer 著者: Jaume Capdevila, L. Iglesias, Irene Halperín, Ángel Segura, Javier Martínez‐Trufero, María Ángeles Vaz Salgado, J. Corral, Gabriel Obiols, Enrique Grande, Juan J. Grau, Josep Tabernero

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

    Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors 著者: Catherine Lombard‐Bohas, James C. Yao, Timothy J. Hobday, Eric Van Cutsem, Edward M. Wolin, Ashok Panneerselvam, Sotirios Stergiopoulos, Manisha H. Shah, Jaume Capdevila, Rodney F. Pommier

    出版事項 2014
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results

    Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results 著者: Marianne Pavel, Jarosław B. Ćwikła, Catherine Lombard‐Bohas, Ivan Borbath, Tahir Shah, Ulrich F. Pape, Jaume Capdevila, Francesco Panzuto, Xuan-Mai Truong Thanh, Aude Houchard, Philippe Ruszniewski

    出版事項 2021
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

    Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer 著者: Bruce Robinson, Martin Schlumberger, Lori J. Wirth, Corina E. Dutcus, James Song, Matthew H. Taylor, Sung‐Bae Kim, Monika K. Krzyzanowska, Jaume Capdevila, Steven I. Sherman, Makoto Tahara

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Libretto-531: A Phase III Study of Selpercatinib in Multikinase Inhibitor-Naïve <i>RET</i> -Mutant Medullary Thyroid Cancer

    Libretto-531: A Phase III Study of Selpercatinib in Multikinase Inhibitor-Naïve <i>RET</i> -Mutant Medullary Thyroid Cancer 著者: Lori J. Wirth, Marcia S. Brose, Rossella Elisei, Jaume Capdevila, Ana O. Hoff, Mimi I. Hu, Makoto Tahara, Bruce Robinson, Ming Gao, Xia Meng, Patricia Maeda, Eric J. Sherman

    出版事項 2022
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

    ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors 著者: Massimo Falconi, Barbro Eriksson, Gregory Kaltsas, Detlef K. Bartsch, Jaume Capdevila, Martyn Caplin, Beata Kos‐Kudła, Dik J. Kwekkeboom, Guido Rindi, Günter Klöppel, Nicholas S. Reed, Réza Kianmanesh, Robert T. Jensen

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer

    Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer 著者: Garazi Serna, Fiorella Ruíz‐Pace, Jorge Hernando, Lidia Alonso, Roberta Fasani, Stefania Landolfi, Raquel Comas, José Jiménez, Elena Élez, Susan Bullman, Josep Tabernero, Jaume Capdevila, Rodrigo Dienstmann, Paolo Nucíforo

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors

    A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors 著者: Josep Tabernero, Luc Dirix, Patrick Schöffski, Andrés Cervantes, José A. López-Martín, Jaume Capdevila, Ludy van Beijsterveldt, Suso Platero, Brett M. Hall, Zhilong Yuan, R.E. Knoblauch, Sen Hong Zhuang

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: